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Mechanisms underlying human germ cell devel-
opment are unclear, partly due to difficulties in
studying human embryos and lack of suitable
experimental systems. Here, we show that human
induced pluripotent stem cells (hiPSCs) differen-
tiate into incipient mesoderm-like cells (iMeLCs),
which robustly generate human primordial
germ cell-like cells (hPGCLCs) that can be pu-
rified using the surface markers EpCAM and
INTEGRINa6. The transcriptomes of hPGCLCs
and primordial germ cells (PGCs) isolated from
non-human primates are similar, and although
specification of hPGCLCs and mouse PGCs rely
on similar signaling pathways, hPGCLC specifi-
cation transcriptionally activates germline fate
without transiently inducing eminent somatic pro-
grams. This includes genes important for naive
pluripotency and repression of key epigenetic
modifiers, concomitant with epigenetic reprogram-
ming. Accordingly, BLIMP1, which represses so-
matic programs in mice, activates and stabilizes a
germline transcriptional circuit and represses a
default neuronal differentiation program. Together,
these findings provide a foundation for understand-
ing and reconstituting human germ cell develop-
ment in vitro.178 Cell Stem Cell 17, 178–194, August 6, 2015 ª2015 Elsevier Inc.INTRODUCTIONThe germ cell lineage is a foundation for totipotency, perpetu-
ating genetic as well as epigenetic information across genera-
tions in most multicellular systems. Accordingly, in humans,
anomalies in the germline, which arises from primordial germ
cells (PGCs) and forms either spermatozoa or oocytes through
complex developmental pathways, lead to a variety of critical
conditions, including infertility, impaired development/physi-
ology, and a diverse array of genetic/epigenetic disorders within
offspring. A precise understanding of the mechanism for germ
cell development therefore bears significant implications not
only in biology in general, but also in a broad range of human
diseases.
The mechanism for germ cell development in mammals has
most extensively been studied using the mouse as a model
organism, providing essential information practically applicable
to all mammals, including humans. On the other hand, among
diverse mammalian species, there exist significant differences
in the precise mechanisms for germ cell development, which
necessitates careful species-by-species studies for a precise
understanding of germ cell development in a given species. In
this regard, there is a critical lack of information as to the mech-
anism for germ cell development in humans, mainly due to the
difficulties/limitations in accessing relevant experimental mate-
rials. This has been an impediment for the diagnosis/treatment
of disorders arising from defects in human germ cells. It would
therefore represent a promising breakthrough over these limita-
tions if human germ cell development could be reconstituted
in vitro from human pluripotent stem cells (hPSCs), including
human embryonic stem cells (hESCs) (Thomson et al., 1998)
and human induced pluripotent stem cells (hiPSCs) (Takahashi
et al., 2007).
Accordingly, recent studies have demonstrated the reconsti-
tution in vitro of the specification and development of the mouse
germline by PSCs (Hayashi et al., 2011, 2012a): mouse (m)
ESCs/iPSCs with ground state pluripotency (Ying et al., 2008)
are induced into pre-gastrulation epiblast-like cells (EpiLCs),
which are in turn induced into PGC-like cells (PGCLCs) with
robust capacity for both spermatogenesis and oogenesis, and
for the generation of offspring; these findings suggest a concep-
tual framework and feasibility for the reconstitution of human
germ cell development in vitro. However, hESCs/iPSCs have
been shown to have differentiation potential and other properties
distinct frommESCs/iPSCs and bear a primed pluripotency with
similarity to mouse epiblast stem cells (EpiSCs) (Brons et al.,
2007; Tesar et al., 2007), which resemble post-gastrulation epi-
blasts and bear a limited, if any, potential for the germ cell fate
(Hayashi et al., 2011). It therefore remains unknown whether
hESCs/iPSCs can be efficiently induced into a human germ
cell fate through an appropriate developmental pathway,
although a number of reports have shown that random differen-
tiation of hESCs/iPSCs yields germ cell-like cells at low effi-
ciency (reviewed by Hayashi et al., 2012b).
We here explored the possibility of inducing the germ cell fate
fromhiPSCs under a defined condition.We observed a robust in-
duction, frommultiple hiPSC lines with primed pluripotency, of a
cellular state similar to hPGCs, which we designated hPGCLCs,
based on a number of stringent criteria.
RESULTS
Establishment of hiPSCs Bearing Double Germline
Reporters
We set out to establish hiPSC lines bearing reporters that mark
hPGC specification. We selected BLIMP1/PRDM1 and TFAP2C/
AP2g as candidates that show expression upon hPGC specifica-
tion, since Blimp1 and Tfap2c encode transcription factors (TFs)
necessary and sufficient for mouse PGC specification (Nakaki
et al., 2013; Ohinata et al., 2005; Weber et al., 2010), and since
BLIMP1 and TFAP2C have been reported to be expressed in
human fetal germ cells (Eckert et al., 2008; Pauls et al., 2005).
We cultured two independent lines of male hiPSCs, 585A1 and
585B1, derived from peripheral mononuclear blood cells
(PMBCs) (Okita et al., 2013), under a feeder-free, defined condi-
tion with basic fibroblast growth factor (bFGF) on the E8 frag-
ment of recombinant LAMININ511 (rLN511E8) (Nakagawa
et al., 2014). The hiPSCs cultured under this condition allow sin-
gle-cell passage, exhibit a homogeneous property, and show
gene expression of a primed pluripotent state (Nakamura et al.,
2015). Using a TALEN (transcription activator-like effector
nucleases)-based strategy (Sakuma et al., 2013), we isolated
several homologous recombinants bearing both the BLIMP1-
2A-tdTomato (BT) and the TFAP2C-2A-EGFP (AG) alleles, and
we selected one line, BTAG 585B1-868, which bears both
recombinant alleles in a heterozygous fashion and a normal kar-
yotype, for subsequent studies (Figure 1A, Figures S1A–S1D).
The BTAG alleles activated tdTomato and EGFP upon BLIMP1
and TFAP2C expression, respectively (Figure S1E).CDirect Induction of BTAG-Positive (+) Cells from hiPSCs
Given that hiPSCs bear a primed pluripotency, we first explored
whether the hiPSCs can be induced directly into hPGCLCs under
a condition that induces EpiLCs into mPGCLCs (Hayashi et al.,
2011). The BTAG hiPSCs were dissociated into single cells
and were cultured under a floating condition in GMEM + 15%
knockout serum replacement (KSR) (GK15) with bone morpho-
genetic protein 4 (BMP4), stem cell factor (SCF), leukemia inhib-
itory factor (LIF), and epidermal growth factor (EGF) (3,000 cells/
aggregate) in the presence of a ROCK inhibitor (Figure 1B) (Wa-
tanabe et al., 2007).
The hiPSC aggregates did not show BT or AG expression at
day 2 of stimulation by inspection under a fluorescent dissection
microscope, and they appeared somewhat fragile (Figure 1C).
However, notably, at day 4, some cells initiated BTAG expres-
sion, and at day 6, a distinct population of cells exhibited strong
BTAG, which persisted at least until day 8 (Figure 1C). Consis-
tently, fluorescence activated cell sorting (FACS) analyses re-
vealed that at day 2, the entire aggregates shifted toward a state
weakly positive for BTAG, and at day 4, 15% of the cells
became BTAG(+) with BT and AG being upregulated at a similar
kinetics, and at day 6–8, there appeared a distinct population
of BTAG(+) cells (20%) (Figure 1D). The efficiency for the
induction of the BTAG(+) cells was the highest when we started
induction with 3,000 cells/aggregate and usedmore than 10%of
KSR as the basal medium (Figure S1F), and the average number
of BTAG(+) cells per aggregate at day 6 was around 200
(Figure 1E).
We examined gene expression dynamics during the BTAG(+)
cell induction by qPCR. The hiPSCs expressed high/middle
levels of the key pluripotency genes POU5F1, NANOG, and
SOX2 (1,000, 40, and 150 copies per cell, respectively),
whereas they showed low/no expression of genes associated
with naive pluripotency in mice (they did, however, express
ZFP42 and PRDM14 at a relatively high level ([20–40 copies))
(Figure 1F). They showed no/very low expression of genes asso-
ciated with PGCs, neuroectoderm, mesoderm, and endoderm
(Figure 1F). At day 2 of stimulation, the aggregates upregulated
key pluripotency genes, remained low for naive pluripotency
genes, and initiated upregulation of genes for PGCs (BLIMP1
and TFAP2C, 20 and 150 copies, respectively), mesoderm
(T, EOMES, SP5, and NODAL, 10–40 copies), and endoderm
(GATA4 and SOX17, a few copies) (Figure 1F). The BTAG(+)
cells at day 6 highly upregulated POU5F1 and NANOG (4,000
and 600 copies, respectively), but became negative for SOX2
(Figure 1F), consistent with the observation that hPGCs lack
SOX2 expression (de Jong et al., 2008; Perrett et al., 2008).
They exhibited high levels of early PGC markers such as
BLIMP1, TFAP2C, andNANOS3 (150,600, and600 copies,
respectively), as well asSOX17 (300 copies), but remained low/
negative for DPPA3 (a few copies) and late PGC genes (DAZL
and DDX4) (Figure 1F). They showed only modest/low levels of T
and PRDM14 (50 and 10 copies, respectively), which are
essential for PGC specification in mice (Aramaki et al., 2013;
Yamaji et al., 2008) (Figure 1F). Additionally, they upregulated
genes for naive pluripotency (KLF4, TCL1B, and TFCP2L1,with
100, 100, 40 copies, respectively), mesoderm (EVX1 and
MSX2, 70 and 150 copies, respectively), and endoderm
(GATA4, 70 copies) (Figure 1F). These findings suggest thatell Stem Cell 17, 178–194, August 6, 2015 ª2015 Elsevier Inc. 179
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Figure 1. Induction of BTAG(+) Cells Directly from hiPSCs
(A) (Left) A phase-contrast image of BTAG 585B1-868 hiPSCs. Bar, 200 mm. (Right) FACS analysis for OCT3/4, SOX2, NANOG, TRA-1-60, and SSEA-4 expression
in BTAG 585B1-868 hiPSCs.
(B) Scheme for direct induction of BTAG(+) cells from hiPSCs.
(legend continued on next page)
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hPSCs bear the competence for the germ cell fate and the
BTAG(+) cells correspond to early hPGCs.
Robust Induction of BTAG(+) Cells via an Incipient
Mesoderm-like State
We noted that the aggregates directly induced from hiPSCs
included a significant number of dead or dying cells, resulting
in a relatively small yield of the BTAG(+) cells (Figure 1E). We
reasoned that this induction strategy might not be optimal, so
we explored a condition under which to induce hiPSCs into a
more appropriate precursor. We found that by stimulating
hiPSCs with Activin A (ACTA) and a WNT signaling agonist
(CHIR99021 [CHIR]; Ying et al., 2008) in GK15 for around
2 days on a fibronectin-coated plate, hiPSCs were induced
into flat epithelial cells with distinct cell-to-cell boundaries (Fig-
ures 2A–2C), which, upon floating aggregate formation and cyto-
kine stimulation, activated BTAG efficiently as early as day 2
(30%–40%) and yielded BTAG(+) cells robustly (as much as
60% at day 4, from around 400 to 1,000 cells per aggregate
at days 4–6) with lower occurrence of cell death (Figures 2D–
2F and Figure S2A).
The flat epithelial cells expressed genes for (naive) pluripo-
tency at levels similar to hiPSCs, did not show genes for PGCs
or endoderm, and modestly upregulated genes for mesoderm
(T, EOMES, SP5, and MIXL1, with a few, 30, 100, and
50 copies, respectively) (Figures 2C and 2G), indicating that
they represent incipient mesoderm/primitive streak-like cells
(which we designated as iMeLCs). The gene expression profiles
of the BTAG(+) cells induced from iMeLCs were essentially iden-
tical to those of the BTAG(+) cells induced directly from hiPSCs
(Figure 2G). FACS and immunofluorescence (IF) analyses
confirmed the expression of OCT4, NANOG, BLIMP1, TFAP2C,
and SOX17 and the repression of SOX2 in BTAG(+) cells (Figures
2H and 2I). These findings demonstrate that hiPSCs can first be
induced into iMeLCs with upregulation of nascent mesodermal
genes, which, in turn, are induced robustly and with a faster
kinetics into the BTAG(+) cells, a state potentially similar to that
of early hPGCs. The variation of induction efficiency would pre-
sumably depend on the conditions of hiPSCs/iMeLCs, including
their passage numbers, (un)differentiated states, and viability
upon passage/aggregate formation.
We examined the relevant conditions/signaling pathways for
BTAG(+) cell induction through iMeLCs. We found that the dura-
tion of stimulation with ACTA and CHIR is critical for hiPSCs to
acquire a capacitated iMeL state, with a time of approximately
42–48 hr being optimal for the BTAG 585B1-868 hiPSCs (Fig-
ure S2B). Longer stimulation resulted in further upregulation of
mesodermal/endodermal properties and depleted the capacity(C) Bright field (BF) and fluorescence (AG and BT) images of floating aggregates (3
(left) or by no cytokines (right) for 2, 4, 6, and 8 days. Bar, 200 mm.
(D) FACS analysis of BTAG expression during direct induction from hiPSCs by BM
indicate BTAG(+) cells with their percentages.
(E) Box plots for the numbers of BTAG(+) cells per aggregate. The average (horizo
bars) of at least two independent experiments are shown.
(F) Gene expression dynamics during BTAG(+) cell induction at days 0 (hiPSCs),
gene examined, theDCT from the average CT values of the two independent hous
numbers of Arbp and Ppia were estimated (indicated in red) by the qPCR values
experiments is shown on the log2 scale, with SDs. n.d., not detected.
See also Figure S1.
Cfor BTAG(+) cell induction (Figures S2B and S2C). Both ACTA
and CHIR/WNT3A were essential, but both BMP4 and bFGF
were detrimental, for the iMeLC induction (Figures S3A–S3F).
Notably, inhibition of FGF receptor (FGFR) signaling by a specific
inhibitor (FGFRi, PD173074) during iMeLC induction led to more
robust proliferation/survival of cells in the aggregates, including
the BTAG(+) cells bearing appropriate gene expression, resulting
in the generation of higher numbers (but not higher percentages)
of the BTAG(+) cells per aggregate (Figures S3G and S3H).
For BTAG(+) cell induction, BMP4 signaling through activin re-
ceptor-like kinase 2/3 (ALK2/3) was essential (Figures S4A and
S4B). BMP2, but not BMP7 or BMP8A, replaced the role of
BMP4 at an essentially identical concentration (Figure S4C).
SCF, LIF, and EGF played additive roles for the maintenance,
but not induction, of the BTAG(+) cells (Figure S4D). Thus, induc-
tion, proliferation, and survival of BTAG(+) cells involve signaling
molecules similar to those for induction, proliferation, and sur-
vival of mPGCLCs (Hayashi et al., 2011).
BTAG(+) Cells as hPGCLCs
We determined global transcription profiles of key cell types
during BTAG(+) cell and mPGCLC induction and those of
the gonadal PGCs of a non-human primate (a cynomolgus mon-
key; Macaca fascicularis) by using a highly quantitative RNA-
sequencing (RNA-seq) technology (Nakamura et al., 2015). For
cynomolgus monkey (cy) PGCs, we isolated cy embryos at
E43, 50, and 51 (corresponding roughly to around E10.5–13.5
in mice), dissected out the gonads, generated single-cell cDNAs
originated from PGCs [POU5F1(+)] (Figures S5A and S5B), and
analyzed them by the RNA-seq (Figure S5E).
BTAG(+) Cells Show a Transcription Profile Similar to
That of cyPGCs
Unsupervised hierarchical clustering (UHC) classified the cells
during BTAG(+) cell induction into two large clusters, one with
hiPSCs and iMeLCs, and the other with d2–d8 BTAG(+) cells
(Figure 3A). Notably, d4 BTAG(+) cells induced from iMeLCs
formed a sub-cluster with d6 BTAG(+) cells induced directly
from hiPSCs (Figure 3A), suggesting that in floating aggregates,
hiPSCs progress to BTAG(+) cells via a pathway similar to that for
BTAG(+) cell induction through iMeLCs. Consistently, principal
component analysis (PCA) revealed a directional and progres-
sive transition of cellular properties during BTAG(+) cell induction
(Figure 3B).
We compared the gene expression of the BTAG(+) cells with
that of cyPGCs. To this end, we generated single-cell cDNAs
from a line of cyESCs, CMK9 (Suemori et al., 2001) (Figures
S5C and S5D), subjected these cDNAs to the RNA-seq analyses
(Figure S5E), identified differentially expressed genes (DEGs),000 cells/initial aggregate) of hiPSCs stimulated by BMP4, SCF, EGF, and LIF
P4, SCF, EGF, and LIF (top) or by no cytokines (bottom) for 8 days. Boxed areas
ntal line), 25th and 75th percentiles (box), and the maximum and minimum (error
2 (whole aggregates), and 6 [BTAG(+) cells], as measured by qPCR. For each
ekeeping genes Arbp and Ppia (set as 0) were calculated and plotted. The copy
of the spike-in RNAs. For each point, the average value from two independent
ell Stem Cell 17, 178–194, August 6, 2015 ª2015 Elsevier Inc. 181
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Figure 2. Induction of BTAG(+) Cells from hiPSCs through iMeLCs
(A) Scheme for BTAG(+) cell induction through iMeLCs.
(B) A phase-contrast image of BTAG hiPSCs (top) and iMeLCs (bottom). Bar, 200 mm.
(C) FACS analysis for OCT3/4, SOX2, and NANOG expression in iMeLCs (42 hr induction).
(legend continued on next page)
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between cyESCs and cyPGCs, and determined their human
orthologs (Table S1). Remarkably, scatter plot analyses showed
that the genes up- or downregulated in cyPGCs were generally
up- or downregulated in d6 BTAG(+) cells compared to
iMeLCs/hiPSCs, but notably, this trend was much weaker in the
comparisonbetweenmPGCLCs andEpiLCs (Figure 3C). Consis-
tently, UHC analysis with genes upregulated in cyPGCs revealed
that d2–d8 BTAG(+) cells were clusteredwith cyPGCs: the genes
co-expressed between the BTAG(+) cells and cyPGCs were
enriched with those bearing gene ontology (GO) terms such as
‘‘stem cell maintenance,’’ ‘‘reproductive developmental pro-
cess,’’ and ‘‘gamete generation’’ (Figure 3D). A group of genes
exclusively expressed in cyPGCs represented late PGC genes
(the GO terms such as ‘‘sexual reproduction’’ and ‘‘sex differen-
tiation’’) (Figure 3D). Thus, the BTAG(+) cells bear gene expres-
sion profiles similar to those of early cyPGCs, and mPGCLCs
show markedly different gene expression from cyPGCs, most
likely due to the species difference.
Comparison of BTAG(+) Cells with Gonadal hPGCs and
NANOS3/TNAP(+) Cells by Irie et al.
Recently, based on the concept of mPGCLC induction, Irie et al.
reported the induction of TNAP/NANOS3(+) cells with a tran-
scriptome similar to that of gonadal hPGCs at 7 weeks of gesta-
tion from hESCs/hiPSCs cultured with four kinase inhibitors (4i)
(Irie et al., 2015). We compared transcriptional profiles of the
BTAG(+) cells with those of hPGCs and TNAP/NANOS3(+) cells.
Since the methods for cDNA preparation and the platforms for
RNA-seq were different between the two studies, it was not
possible to perform a strict comparison of their transcriptome
data. We therefore first identified DEGs between H9 ESCs and
gonadal hPGCs (Table S2) and examined their expression in
our samples. Remarkably, genes up- or downregulated in
hPGCs were almost exclusively up- or downregulated in the
BTAG(+) cells compared to iMeLCs (Figure 3E). The heat map
for the expression of genes upregulated in hPGCs in our samples
and those of Irie et al. revealed that a majority of them, except
mainly late PGC genes, were upregulated similarly in BTAG(+)
cells and TNAP/NANOS3(+) cells (Figure 3F).
We next identified the DEGs between pre-induced cells and
TNAP/NANOS3(+) cells by Irie et al. and examined their expres-
sion in our cells; reciprocally, we identified the DEGs between
iMeLCs andBTAG(+) cells and examined their expression in cells
by Irie et al. This analysis revealed that the gene expression pro-
files of BTAG(+) cells and TNAP/NANOS3(+) cells are highly
correlated (Figure 3G). Collectively, these findings indicate that
the BTAG(+) cells bear similar transcription profiles to hPGCs
and TNAP/NANOS3(+) cells. Combined with our analysis on
cyPGCs, this led us to designate the BTAG(+) cells as hPGCLCs.(D) Bright field (BF) and fluorescence (AG and BT) images of floating aggregates (3
(left) or by no cytokines (right) for 2, 4, 6, and 8 days. Bar, 200 mm.
(E) FACS analysis of BTAG induction in aggregates of iMeLCs stimulated by BMP
indicate BTAG(+) cells with their percentages.
(F) Box plots (as shown in Figure 1E) demonstrating the percentages (left) and th
(G) Gene expression dynamics during BTAG(+) cell induction for 8 days, as measu
experiments) were as shown in Figure 1F. Filled circles: values for BTAG(+) cells
(H) FACS analysis for OCT3/4, SOX2, and NANOG expression in d4 BTAG(+) ce
(I) IF of BLIMP1, TFAP2C, SOX2, and SOX17 expression in d8 BTAG(+) PGCLCs
See also Figures S2–S4.
CA Unique Pathway for hPGCLC Specification
The numbers of genes up- or downregulated between the cell-
state transitions during hPGCLC induction were substantially
smaller compared to those showing such regulation during
mPGCLC induction (Figure 4A, Table S3, and Table S4). The
genes upregulated during the hiPSC-to-iMeLC transition were
enriched with those bearing GO terms such as ‘‘cell migration’’
and ‘‘pattern specification process,’’ whereas those downregu-
lated were enriched with those for ‘‘chemical homeostasis’’
and ‘‘cell adhesion’’ (Figure 4B and Table S3). The genes upregu-
lated during the iMeLC-to-d2 hPGCLC transition included po-
tential regulators for hPGCLC specification (e.g., TFAP2C,
PRDM1,SOX17,SOX15,KLF4,KIT, TCL1A,DND1, etc.) (Figures
3C and 4B and Table S3) andwere enrichedwith genes for ‘‘stem
cell maintenance’’ and ‘‘regulation of cell migration,’’ whereas
those downregulated were enriched with genes for ‘‘pattern
specification process’’ and ‘‘neuron development’’ (Figure 4B
and Table S3). The gene expression changes between d2 and
d4 hPGCLCs were relatively minor, with a few genes for ‘‘embry-
onic morphogenesis’’ downregulated in d4 hPGCLCs, and the
gene expression profiles of the d6 and d8 hPGCLCswere essen-
tially identical (Figures 4A and 4B and Table S3).
We identified genes expressed at the highest level in each cell
type during hPGCLC and mPGCLC induction (Figure 4C). A key
event for mPGC/PGCLC induction is acute and robust activation
with subsequent repression of ‘‘a somatic mesodermal pro-
gram’’ (Kurimoto et al., 2008; Saitou et al., 2002; Yabuta et al.,
2006). Consistently, genes with the highest expression in d2
mPGCLCs (the d2 mPGCLC genes) were the largest in number
(n = 756) and were enriched with such GO terms as ‘‘embryonic
morphogenesis’’ and ‘‘pattern specification process’’ with highly
significant p values, and, in a majority of cases, they were
repressed in d4 mPGCLCs (Figures 4C and 4D and Table S4).
In contrast, genes with the highest expression in d2 hPGCLCs
(the d2 hPGCLC genes) were relatively small in number (104), ex-
hibited enrichment in GO terms for ‘‘cellular component morpho-
genesis’’ and ‘‘neuron differentiation,’’ and gradually repressed
in d4 and d6 hPGCLCs (Figures 4C and 4D and Table S3).
Strikingly, the vast majority of the human orthologs of the d2
mPGCLC genes exhibited relatively constant expression (either
not expressed or expressed at similar levels) during hPGCLC in-
duction, while only a minority of the mouse orthologs of the d2
hPGCLC genes showed transient upregulation in d2 mPGCLCs
(Figures 4E–4G, Table S3, and Table S4). Consequently, as few
as 16 genes, not including the Hox genes, were shared in com-
mon between the d2 hPGCLC and mPGCLC genes (Figure 4E
andFigureS5F). These findings revealed adistinct transcriptional
program between hPGCLC andmPGCLC induction and a lack of,000 cells/initial aggregate) of iMeLCs stimulated by BMP4, SCF, EGF, and LIF
4, SCF, EGF, and LIF (top) or by no cytokines (bottom) for 8 days. Boxed areas
e numbers of BTAG(+) cells per aggregate (right).
red by qPCR. The quantifications of gene expression levels (three independent
; filled squares: values for BTAG() cells. n.d., not detected.
lls.
[EGFP(+), dotted lines] compared with those in hiPSCs. Bar, 10 mm.
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prominent activation with subsequent repression of ‘‘a somatic
program’’ during hPGCLC induction, even though hPGCLC and
mPGCLC induction depend on identical signaling molecules.
hiPSCs Bear a Property Intermediate between That of
EpiLCs and EpiSCs
We explored the relationship among hiPSCs, iMeLCs, mESCs,
EpiLCs, and EpiSCs. Since global transcription states between
human and mouse cells are not directly comparable due to the
species difference, first, we selected representative genes in
mice with key functions associated with naive pluripotency and
the pre-gastrulation epiblast, mesoderm, and endoderm and
examined their expression profiles among these cell types.Genes
for naive pluripotency were highly expressed in mESCs, downre-
gulated in EpiLCs, and further downregulated in EpiSCs, whereas
genes for the epiblast were upregulated in both EpiLCs and
EpiSCs (Figure 4H). Genes for the mesoderm and endoderm
were generally low in mESCs and EpiLCs but were upregulated
to some extent in EpiSCs (Figure 4H). Thus, mESCs, EpiLCs,
and EpiSCs bear properties similar to the early epiblast, pre-
gastrulation epiblast, and post-gastrulation epiblast, respectively.
The expression patterns of genes for naive pluripotency in hiPSCs
and iMeLCsweresomewhat similar to those inEpiLCs (Figure4H).
Around half of the selected genes for the pre-gastrulation epiblast
in mice exhibited strong expression in both hiPSCs and iMeLCs.
Consistent with the qPCR analysis (Figures 1F and 2G and Fig-
ure S2C), some of the genes for the mesoderm—but not endo-
derm—wereupregulated in iMeLCs, but not in hiPSCs (Figure 4H).
Second, we classified the genes expressed at relevant levels
among mESCs, EpiLCs, and EpiSCs (Hayashi et al., 2011) into
five classes (Figure S5G). We normalized the expression data
in Hayashi et al. (2011) and the present study, identified the hu-
man orthologs of the five classes of genes, and analyzed their
expression in the relevant cell types, which revealed a trend of
hiPSCs/iMeLCs exhibiting properties intermediate between
those of EpiLCs and EpiSCs (Figure S5H): the averaged expres-
sion levels of the class I and V genes (high in EpiLCs and EpiSCs
and low in EpiLCs and EpiSCs, respectively) in hiPSCs/iMeLCs
were similar to those in EpiLCs and EpiSCs, and the averaged
expression levels of the class II and IV genes (high and low in
EpiSCs, respectively) in hiPSCs/iMeLCs were intermediate be-Figure 3. BTAG(+) Cells as hPGCLCs
(A) UHC of the transcriptomes (two independent experiments) of hiPSCs, iMeLC
directly from hiPSCs (day 6) (blue*).
(B) PCA of cells as in (A). Color codes for the cell types are indicated.
(C) (Left) Scatter plots of the expression of genes upregulated (yellow) or downregu
to cyESCs or their human/mouse orthologs (Table S1) in the indicated cell types.
cyESCs or their human/mouse orthologs plotted against their log2 fold changes
(D) UHC of relevant cell types during BTAG(+) cell induction and of cyESCs (CMK
their human orthologs) upregulated in cyPGCs compared to cyESCs (fold changes
heat map. For cyESCs and cyPGCs, the averaged expression levels of single-c
included are shown for each gene cluster.
(E) (Top) Scatter plots of the expression of DEGs between hPGCs and H9 ESCs (f
et al., 2015) in d6 BTAG(+) cells and iMeLCs. (Bottom) Histogram of the frequenc
changes in the indicated comparison.
(F) UHC of relevant cell types in Irie et al. (in red) (Irie et al., 2015) and the pres
compared to H9 ESCs (fold changes > 4, p < 0.01 by ANOVA one-way test). The
(G) Scatter plots of the log2 fold changes of DEGs between iMeLCs and d4 BTA
between pre-induced cells and d4 TNAP/NANOS3(+) cells (top) and of DEGs b
n = 1,165) plotted against their log2 fold changes between iMeLCs and d4 BTAG
See also Figure S5, Table S1, and Table S2.
Ctween those in EpiLCs and EpiSCs. Based on these observa-
tions, together with the analysis of the expression of key genes
(Figure 4H), we propose that hiPSCs bear a property intermedi-
ate between that of EpiLCs and EpiSCs, andwere able to take on
a germ cell fate with a molecular pathway specific to humans.
Epigenetic Properties of hPGCLCs
We next evaluated the epigenetic properties of hPGCLCs. IF an-
alyses revealed that compared to hiPSCs, d8 hPGCLCs ex-
hibited lower histone H3 lysine 9 di-methylation (H3K9me2)
and DNA methylation levels, whereas they showed variegated
(some higher and others similar) levels of histone H3 lysine 27
tri-methylation (H3K27me3) (Figure S6A). We then examined
the methylation states of differentially methylated regions
(DMRs) of paternally (H19 and MEG3) and maternally
(KCNQ1OT1 and PEG10) imprinted genes in hiPSCs and d8
hPGCLCs by bisulfite pyro-sequencing, which revealed that d8
hPGCLCs may initiate the imprint erasure of H19, but retain the
imprints of MEG3, KCNQ1, and PEG10 (Figure S6B). Thus, the
epigenetic properties of hPGCLCs are similar to those of
mPGCLCs (Hayashi et al., 2011; Kurimoto et al., 2015).
We also examined the expression of epigenetic modifiers dur-
ing hPGCLC induction and in cyPGCs (Figure S6C): among the
molecules involved in DNA methylation, hPGCLCs repressed
DNMT3B, but retained DNMT1 and UHRF1, and cyPGCs
repressed DNMT3A/3B and UHRF1. Among the molecules
involved in DNA demethylation, TET1 showed relatively constant
expression, while other genes showed no/low expression in both
hPGCLCs and cyPGCs. Both hPGCLCs and cyPGCs repressed
EHMT2, a key enzyme for H3K9me2, and they expressed several
H3K9me2 demethylases (KDM1A/3A/3B). Among the molecules
involved in H3K27me3, EZH2 and SUZ12 showed constant
expression during hPGCLC induction, while EED was repressed
in hPGCLCs, whereas cyPGCs strongly expressed EZH2, EED,
and SUZ12.
Identification of Surface Markers for hPGCLCs
We explored surface markers that distinguish hPGCLCs
without the use of fluorescent reporters. Among a number of
markers that we screened, the combination of EpCAM ands, and BTAG(+) cells induced through iMeLCs (days 2, 4, 6, and 8) (black#) or
lated (blue) (fold changes > 4, FDR < 0.01 byWelch t test) in cyPGCs compared
(Right) Histogram of the frequency distribution of DEGs between cyPGCs and
in the indicated comparisons.
9) and cyPGCs (E43, 50, 51, all female) based on the expression of genes (and
> 4, FDR < 0.01 byWelch t test). The gene expression level is represented by a
ell samples were shown. The GO functional terms and representative genes
old changes > 4, p < 0.01 by ANOVA one-way test, up: yellow; down: blue) (Irie
y distribution of DEGs between hPGCs and H9 ESCs plotted against log2 fold
ent study (in black) based on the expression of genes upregulated in hPGCs
normalized gene expression level is represented by a heat map.
G(+) cells (fold changes > 3, n = 1,144) plotted against their log2 fold changes
etween pre-induced cells and d4 TNAP/NANOS3(+) cells (fold changes > 3,
(+) cells (bottom). Pearson’s correlation coefficients (R) are shown.
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INTEGRINa6 segregated the day-6 aggregates from BTAG
hiPSCs into three distinct populations. Remarkably, the
EpCAM-/INTEGRINa6-high population was nearly identical to
the BTAG(+) hPGCLCs [98.9% of the EpCAM-/INTEGRINa6-
high cells were BTAG(+)] and the other two populations were
essentially negative/weak for BTAG (Figure 5A). As early as
day 2 of induction, the EpCAM-/INTEGRINa6-high population
was discernible (37%) and essentially identical to the
BTAG(+) population, and thereafter it became more distinct
and persisted until at least day 8 (Figure 5B).
We induced the 585A1 hiPSCs without the reporters into
hPGCLCs. As early as day 2, there appeared an EpCAM-/
INTEGRINa6-high population (21%), and this population was
increased at days 4 (31%) and 6 (32%) (Figure 5C). To deter-
mine whether this population represented hPGCLCs, we iso-
lated total RNA from the population at day 6 and analyzed
its transcriptome. The UHC revealed that the d6 EpCAM-/
INTEGRINa6-high cells were clustered tightly with d6 and d8
hPGCLCs, demonstrating that they were indeed the hPGCLCs
(Figure 5D). The two newly derived hiPSC lines, 1383D2 and
1383D6 (XY, from PMBCs), were also induced robustly into
EpCAM-/INTEGRINa6-high cells (Figure 5E). Finally, the 201B7
line, the first and one of the most frequently used hiPSC lines
derived from human dermal fibroblasts (XX) (Takahashi et al.,
2007), was induced robustly into EpCAM-/INTEGRINa6-high
cells showing gene expression highly similar to that in hPGCLCs
(Figure 5E). We conclude that hiPSCs with a primed pluripotency
bear a robust competence for germ cell fate.
A Critical Function of BLIMP1 in hPGCLC Specification
We examined the role of BLIMP1 in hPGCLC specification. Since
a knockout of BLIMP1 in BTAG hiPSCs might impair BT expres-
sion in an unpredictable fashion, we generated an hiPSC line
bearing a TFAP2C-2A-EGFP allele (AG 585B1-17, 19) and re-
placed the exon 4 of the BLIMP1 gene with tdTomato (Figure 6A
and Figures S7A and S7B). We isolated several clones in which
BLIMP1 was heterozygously knocked out (BTAG; BLIMP1+/)
and those bearing one BLIMP1 allele with targeted replacement
by tdTomato and another allele with frame-shift deletions
(BLIMP1 homozygously knocked out clones: BTAG; BLIMP1/)
(Figure 6A and Figure S7B).
We induced AG; BLIMP1+/+, BTAG; BLIMP1+/, and BTAG;
BLIMP1/ hiPSCs into hPGCLCs. We confirmed that the AG(+)
cells induced from the BLIMP1/ hiPSCs lacked BLIMP1 (Fig-
ure 6B). The BLIMP1+/+ hiPSCs were robustly induced into AG(+)Figure 4. A Pathway to hPGCLCs
(A) Numbers of genes up- or downregulated (fold change > 2, FDR < 0.01 by ANO
(right) PGCLC specification.
(B) GO analysis of the genes shown in (A) during hPGCLC specification.
(C) Numbers of genes showing the highest expression in each cell type (fold chang
PGCLC specification.
(D) GO analysis of the human and mouse d2 PGCLC genes shown in (C).
(E) Overlap between the human and mouse d2 PGCLC genes shown in (C).
(F and G) Box plots (with the median value and 25th and 75th percentiles, top) an
genes during human (left) and mouse (right) PGCLC specification.
(H) Heat map of the normalized expression of selected genes associated with mo
EpiLCs, EpiSCs, hiPSCs, and iMeLCs. Gene expression data by microarray analys
were used.
See also Figures S5 and S6, Table S3, and Table S4.
ChPGCLCs and were maintained as hPGCLCs (d2: 69.3%; d4:
52.8%; d6: 32.2%; d8: 32.2%) (Figures 6C–6E). In contrast,
althoughBLIMP1/ hiPSCswere induced intoBTAG(+) cells effi-
ciently at day 2 (47.4%; BTAG/AG: 92%), the number of
BTAG(+) cells declined sharply at day 4 (18.8%; BTAG/AG:
98%) and these cells had almost disappeared at day 6
(1.6%) (Figures 6C–6E), indicating that BLIMP1 is essential for
the specification and maintenance of hPGCLCs. We obtained
essentially the same results using the other independent
BLIMP1/ hiPSC line (data not shown). Notably, consistent with
the dose-dependent function of Blimp1 in mice (Ohinata et al.,
2005),BLIMP1+/ hiPSCs exhibited a phenotype intermediate be-
tween thoseof thewild-typeandBLIMP1/hiPSCs (d2:49.6%;
d4: 27.0%; d6: 8.1%; d8: 4.6%) (Figures 6C–6E).
We isolatedRNAs fromd2 andd4 (BT)AG(+) cells induced from
the BLIMP1+/+, BLIMP1+/, and BLIMP1/ hiPSCs, and we first
analyzed the expression of key genes in BLIMP1+/+; AG(+) and
BLIMP1/; BTAG(+) cells by qPCR (Figure 6F). This analysis re-
vealed that, similarly to thewild-type cells,BLIMP1/ cells upre-
gulated POU5F1 and NANOG and repressed SOX2, indicating
that regulation of key pluripotency genes in hPGCLCs is indepen-
dent of BLIMP1.BLIMP1/ cells upregulated TFAP2C normally,
but they exhibited impaired upregulation of genes such as
NANOS3,KLF4, TFCP2L1, and TCL1B. Interestingly,BLIMP1/
cells failed to maintain T and MIXL1, whereas they failed to
repressEVX1 andSP5, and apparently had no effects onEOMES
and MSX2, indicating that BLIMP1 exerts differential effects on
genes associated with mesoderm development. Similarly,
BLIMP1/ cells showed impaired repression of GATA4, but
had no distinct influence on SOX17, GATA6, and FOXA2.
Notably, BLIMP1/ cells were unable to repress DNMT3B.
We compared the transcriptome of BLIMP1/; BTAG(+) cells
with that of wild-type and BLIMP1+/ hPGCLCs by RNA-seq
(Figure S7C). UHC and PCA showed that although BLIMP1/
cells acquired a property similar to that of d2 hPGCLCs, they
failed to progress further toward the d4 PGCLC state (Figures
7A and 7B). We explored genes up- or downregulated in d2
and d4 BLIMP1/ cells in comparison to d2 and d4 PGCLCs,
respectively. The genes upregulated in d2 BLIMP1/ cells
(104 genes) were enriched with genes for ‘‘neuron differentia-
tion,’’ ‘‘gastrulation,’’ and ‘‘embryonic morphogenesis,’’ and
those upregulated in d4 BLIMP1/ cells (692 genes) were en-
riched with similar GO terms with much higher p values, indi-
cating that BLIMP1 functions to repress such developmental
programs in hPGCLCs (Figures 7C and 7D and Table S5).VA one-way test) between key stages/cell types during human (left) and mouse
e > 2, compared to the other 3 cell types) during human (left) and mouse (right)
d heat map (bottom) of the expression of human (F) and mouse (G) d2 PGCLC
use naive pluripotency and the epiblast, mesoderm, and endoderm in mESCs,
is in Hayashi et al. (2011) and data from the present study by RNA-seq analysis
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populations on the left classified by EpCAM and INTEGRINa6 expression.
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Consistent with the qPCR analysis (Figure 6F), among the genes
involved in DNA (de)methylation, BLIMP1/ cells failed to
repress DNMT3B (Figure S7D). In contrast, the genes downregu-
lated in BLIMP1/ cells were smaller in number and were en-
riched with GO terms related to apoptosis and the cell cycle,
suggesting mis-regulation of a fundamental cellular property in
BLIMP1/ cells (Figures 7C and 7D and Table S5).
The genes up- or downregulated in d2 BLIMP1/ cells,
including those for ‘‘neuron differentiation’’ and ‘‘embryonic
morphogenesis,’’ exhibited differential expression patterns dur-
ing hPGCLC induction; notably, in BLIMP1+/ cells, these genes
were expressed at intermediate levels between wild-type and
BLIMP1/ cells (Figure 7E). Since genes for ‘‘neuron differenti-
ation’’ and its related GO terms were highly enriched in genes
upregulated in BLIMP1/ cells, we explored the expression dy-
namics of such genes during hPGCLC induction and the impact
of the BLIMP1 deficiency on their expression. These genes were
classified into several expression categories and those upregu-
lated inBLIMP1/ cells were eminently included in both expres-
sion categories for upregulation (18/39,46%) and downregula-
tion (6/23, 26%) in d2 hPGCLCs (Figure 7F). It is also notable
that the 15 genes without significant expression changes during
hPGCLC induction were upregulated in BLIMP1/ cells (Fig-
ure S7E). Thus, the key functions of BLIMP1 include the repres-
sion, in a dose-dependent fashion and to appropriate levels, of
genes for ‘‘neuron differentiation’’ that are upregulated in d2
hPGCLCs, as well as the proper repression of such genes that
are downregulated in d2 hPGCLCs.
DISCUSSION
The precise definition of hPGCLCs involves an inherent difficulty
due to the lack of information regarding the properties of early
hPGCs. Nonetheless, we showed that the BTAG(+) cells bear
properties highly similar to those of early cy and hPGCs (Figures
3C, 3D, and 3F) and defined them as hPGCLCs (Figure 7G). Our
finding that hPGCLCs are robustly induced from hiPSCs in a
primed pluripotent state, in particular through iMeLCs, is surpris-
ing, since EpiSCs with primed pluripotency show little, if any,
competence for thegermcell fate (Hayashi et al., 2011).However,
it is important to note that hiPSCs/hESCs and EpiSCs do show
differences in their properties (e.g., hiPSCs/hESCs express
PRDM14, but EpiSCsdonot [Chia et al., 2010;Nakaki andSaitou,
2014]) and it is difficult to strictly compare the properties between
hiPSCs/hESCs and EpiSCs due to the species difference. We
provided evidence that hiPSCs cultured under our conditions
have a property intermediate between EpiLCs and EpiSCs (Fig-
ure 4H and Figure S5H). A definitive conclusion would require ex-
periments such as an investigation into the properties of early
post-implantation epiblasts in non-human primate models.(C) FACS by EpCAM and INTEGRINa6 expression of cells during hPGCLC indu
iMeLCs. Full: induction by BMP4, LIF, SCF, and EGF. The percentages of cells i
(D) UHC of the transcriptomes (two independent experiments) of hiPSCs, iMeLC
INTEGRINa6-high cells (day 6) induced from 585A1 hiPSCs through iMeLCs (in r
(E) (Top) FACS by EpCAM and INTEGRINa6 expression of d6 aggregates induce
with FGFRi. (Middle and bottom) (Left) FACS by EpCAM and INTEGRINa6 expr
induced without (middle) or with (bottom) FGFRi. (Right) Comparison of expressio
Study) in the P3 and P5 populations with those in d4 BTAG(+) cells with correlat
CWe demonstrated that signaling requirements for the induc-
tion and proliferation/survival of hPGCLCs are similar to those
for mPGCLCs, whereas downstream transcriptional programs
are highly different between hPGCLCs and mPGCLCs, most
likely due to the different regulatory structures of the genome
between the two species (Figures 3C and 4). Importantly, more-
over, unlike in the process for mPGC/PGCLC specification,
transient activation and subsequent repression of the somatic
mesodermal program are not eminent in hPGCLC specification,
which, rather, appears to involve a more straightforward pro-
gramming (Figure 4). Although a definitive conclusion would
again require investigation in vivo in appropriate models, this
might be a reflection of a potentially different mode of PGC
specification arising from different time requirements and/or
embryonic structures between mice and humans (and many
other mammals) during the relevant period for PGC specification
(Hayashi et al., 2012b; Saitou and Yamaji, 2010). In this regard, it
would be interesting to investigate whether T, a conserved
mesodermal TF critical in mPGC specification (Aramaki et al.,
2013), plays a similar role in hPGC specification.
We demonstrated that BLIMP1 is essential for hPGCLC spec-
ification (Figures 6 and 7), as it is for mPGC/mPGCLC specifica-
tion (Kurimoto et al., 2008; Ohinata et al., 2005) (data not
shown). The initial induction of BTAG(+) cells from BLIMP1/
hiPSCs appeared normal, but BTAG(+) cells sharply declined
thereafter and eventually disappeared (Figure 6). Contrary to a
previous report (Lin et al., 2014), BLIMP1/ cells repressed
SOX2 in an essentially normal fashion, indicating that SOX2
repression is mediated by BMP4 signaling but is independent
from BLIMP1 (Figure 6F). Consistent with a less prominent acti-
vation of the somatic mesodermal program during hPGCLC
induction (Figure 4), the role of BLIMP1 in repression of such
a program was variable and BLIMP1 was instead critical in acti-
vating genes potentially critical for PGCs and repressing genes
for ‘‘neuron differentiation,’’ which may be an inherent/default
program for differentiation from hiPSCs (Figure 7). Thus, the
precise role of BLIMP1 appears to have diverged between
mice and humans.
Based on the concept of mPGCLC induction, two recent pa-
pers reported the induction of hPGCLCs from hESCs/hiPSCs
(Irie et al., 2015; Sugawa et al., 2015). We showed that the tran-
scriptional profiles of BTAG(+) cells are similar to those of TNAP/
NANOS3(+) cells by Irie et al. (Figures 3E–3G). In contrast, cells
by Sugawa et al. appear to exhibit different gene expression
from BTAG(+) cells [e.g., fold enrichment ( 3 ) from hiPSCs,
BTAG(+) cells versus KIT/TRA-1-81(+) cells in Figures 2D and
5C by Sugawa et al.: OCT4: 3 4 versus 3 0.25; NANOG: 3 16
versus 3 1; SOX2: undetectable versus  3 0.4; BLIMP1:
more than 3 1,000 versus  3 20; TFAP2C: 3 250 versus 3 1;
NANOS3: more than 3 1,000 versus  3 30], suggesting thatction (until day 6) from 585A1 hiPSCs without fluorescent reporters through
n the P3 gate are shown.
s, and BTAG(+) cells induced through iMeLCs (day 2, 4, 6, and 8) and EpCAM/
ed).
d from 1383D2 (left) and 1383D6 (right) through iMeLCs. iMeLCs were induced
ession of d4 aggregates induced from 201B7 through iMeLCs. iMeLCs were
n levels of relevant genes (see Supplemental Information, Primers Used in This
ion coefficients (R).
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Figure 6. BLIMP1 Is Essential for hPGCLCs
(A) Scheme of the targeting vector for BLIMP1 and the targeted allele and the deletions of the BLIMP1 locus.
(B) IF analysis for AG (top, green) and BLIMP1 (bottom, red) expression in AG;BLIMP1+/+ or BTAG; BLIMP1/ cells induced from hiPSCs (BLIMP1+/+: clone 1-7,
1-9; BLIMP1/: clone 1-7-5, 1-9-6) through iMeLCs. Bar, 10 mm.
(C) Bright field (BF) and fluorescence (AG and BT) images of floating aggregates (3,000 cells/initial aggregate) induced from wild-type (left), BTAG; BLIMP1+/
(middle), or BTAG; BLIMP1/ (right) hiPSCs through iMeLCs stimulated by BMP4, SCF, EGF, and LIF for 2, 4, and 6 days. Bar, 200 mm.
(legend continued on next page)
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the cells by Sugawa et al. are not properly sorted or induced.
Notably, the hPSCs in 4i by Irie et al. did not show consistent up-
regulation of genes for naive pluripotency, but rather exhibited
upregulation ofmesodermalmarkers, suggesting that the hPSCs
in 4i are not in the postulated naive state, but rather in a type
of peri-gastrulating epiblast-like state, similar to iMeLCs. The
different competence of hPSCs for hPGCLC induction between
the two studiesmight result from different culture conditions; i.e.,
we cultured hiPSCs under a feeder-free, defined condition on
rLN511E8, whereas Irie et al. maintained hPSCs on feeders in
different culture media. Our finding that hPGCLCs are induced
robustly from a primed state through iMeLCs would necessitate
a reconsideration of the definition of naive pluripotency and pro-
vide a critical opportunity to define the spectrum of human
pluripotent states.
The hPGCLCs do not show expression of late PGC markers
such as DAZL and DDX4 even at day 12 of induction (Figures
1–3 and Figure S4E) and thus would correspond to early hPGCs.
The late PGC genes have been shown to be repressed by
H3K27me3 and H3K9me2 as well as by DNA methylation in
mPGCLCs (Kurimoto et al., 2015) (data not shown) and exhibit
strong upregulation upon aggregation with embryonic gonads,
particularly with female embryonic gonads (Hayashi et al.,
2012a). To further reconstitute human germ cell development
in vitro, one of the key challenges would therefore be to explore
whether it is possible to further differentiate hPGCLCs into those
with a later hPGC phenotype. Such studies woud also highlight
the mechanism of epigenetic reprogramming in the human
germ cell lineage.
EXPERIMENTAL PROCEDURES
All the animal experiments were performed under the ethical guidelines of
Kyoto University and Shiga University of Medical Science. The experiments
on the induction of hPGCLCs from hiPSCs were approved by the Institutional
Review Board of Kyoto University and were performed according to the guide-
lines from the Ministry of Education, Culture, Sports, Science, and Technology
(MEXT) of Japan. The experimental procedures for generation of the BTAG-
knockin reporter lines; generation of BLIMP1-knockin/knockout hiPSCs; kar-
yotyping and G-band analyses; FACS analysis; qPCR and RNA-seq analyses;
mapping reads of RNA-seq and conversion to gene expression levels;
comparison of gene expression among humans, cynomolgus monkeys, and
mice; transcriptome analysis; immunofluorescence analysis; and bisulfite
pyrosequencing are available in the Supplemental Information.
Culture of hiPSCs
The hiPSC lines (201B7, 585A1, and 585B1 were maintained under a conven-
tional condition (Dulbecco’s modified Eagle medium [DMEM/F12; Life Tech-
nologies] supplemented with 20% [v/v] KSR [Life Technologies], 1%GlutaMax
[Life Technologies], 0.1 mM nonessential amino acids, 4 ng/ml recombinant
human bFGF [Wako Pure Chemical Industries], and 0.1 mM 2-mercaptoetha-
nol) onmitomycin C (MMC)-inactivated SNL feeder cells (Okita et al., 2013) and
were subsequently adapted to a feeder-free condition (StemFit [Ajinomoto,
Tokyo, Japan] medium on recombinant LAMININ511 [rLN511E8] [iMatrix-(D) FACS analysis of the induction of (BT)AG(+) cells for 8 days from wild-type (top
iMeLCs. Boxed areas indicate (BT)AG(+) cells with their percentages.
(E) Numbers (two independent experiments with SDs) of (BT)AG(+) cells per agg
BTAG; BLIMP1/ (ko: square) hiPSCs through iMeLCs.
(F) Gene expression profiles of d2 and d4 (BT)AG(+) cells induced from wild-type
fication of gene expression levels (two independent experiments) were as descr
See also Figure S7.
C511, Nippi, Tokyo, Japan]-coated cell culture plates) (Nakagawa et al.,
2014). The 1383D2 and 1383D6 lines were derived and cultured under the
feeder-free condition. For the passage or the induction of differentiation, the
cells were treated with a 1 to 1 mixture of TrypLE Select (Life Technologies)
and 0.5 mM EDTA/PBS to enable their dissociation into single cells, and
10 mM of a ROCK inhibitor (Y-27632; Wako Pure Chemical Industries) was
added for 24 hr after plating.
Induction of iMeLCs and hPGCLCs
The iMeLCs were induced by plating 1.0–2.0 3 105 hiPSCs maintained in
StemFit onto a well of a human plasma fibronectin (Millipore, FC010)-coated
12-well plate in GK15 medium (GMEM [Life Technologies] with 15% KSR,
0.1 mMNEAA, 2 mM L-glutamine, 1 mM sodium pyruvate, and 0.1 mM 2-mer-
captoethanol) containing 50 ng/ml of ACTA, 3 mM of CHIR, and 10 mM of a
ROCK inhibitor (Y-27632; Wako Pure Chemical Industries). The hPGCLCs
were induced by plating 3.0 3 103 iMeLCs or iPSCs into a well of a low-cell-
binding V-bottom 96-well plate (Thermo, 81100574) in GK15 supplemented
with 1,000 U/ml (5,000 U/ml for 201B7) of LIF (Millipore, #LIF1005),
200 ng/ml of BMP4, 100 ng/ml (200 ng/ml for 201B7) of SCF (R&D Systems,
455-MC), 50 ng/ml (250 ng/ml for 201B7) of EGF (R&D Systems, 236-EG),
and 10 mMof the ROCK inhibitor. In some experiments, PD173074 (StemGent,
#04-0008) or LDN193189 (StemGent, #04-0074) was added for iMeLC or
hPGCLC induction, respectively. In other experiments, WNT3A (R&DSystems,
5036-WN) was used in place of CHIR, and BMP2 (R&D Systems, 355-BM),
BMP7 (R&D Systems, 354-BP), or BMP8A (R&D Systems, 1073-BP) was
used in place of BMP4.
Preparation of Single-Cell cDNAs from cyESCs and cyPGCs
cyESCs (CMK9) were the gift of Dr. Suemori (Suemori et al., 2001). They were
cultured with conventional hESCmedium (DMEM/F12 [Life Technologies] sup-
plemented with 20% [vol/vol] of KSR [Life Technologies], 1 mM of sodium py-
ruvate [Life Technologies], 2 mM of GlutaMax [Life Technologies], 0.1 mM of
nonessential amino acids [Life Technologies], 0.1 mM of 2-mercaptoethanol
[Sigma-Aldrich], 1000 U/ml of ESGROmouse LIF [Millipore], and 4 ng/ml of re-
combinant human bFGF [Wako Pure Chemical Industries]) on mouse embry-
onic feeders (MEFs). For isolating single cells for the single-cell mRNA 3-prime
end sequencing (SC3-seq) analysis (Nakamura et al., 2015), cells were first de-
tached as clumps with CTK solution (0.25% of Trypsin [Life Technologies],
0.1 mg/ml of Collagenase IV [Life Technologies], and 1 mM of CaCl2 [Nacalai
Tesque]), incubated in 0.25% trypsin/PBS (Sigma-Aldrich) for around 10 min
at 37C, and dispersed into single cells in 1% (vol/vol) KSR/PBS.
The technologies in cynomolgus monkeys for oocyte collection, intra-cyto-
plasmic sperm injection (ICSI), pre-implantation embryo culture, and transfer
of pre-implantation embryos into foster mothers were reported previously
(Yamasaki et al., 2011). Implanted embryos were monitored by ultrasound
diagnosis and recovered by Caesarian section at embryonic days 43, 50,
and 51. The gender of the embryos was determined by sex-specific PCR on
genomic DNA isolated from somatic tissues (Wilson and Erlandsson, 1998).
Genital ridges were dissected out and were dissociated into single cells by
being incubated with 0.25% trypsin/PBS for around 10 min at 37C followed
by repeated pipetting. The resulting single cells were dispersed in 0.1 mg/ml
of PVA/PBS (Sigma-Aldrich) and were processed for the SC3-seq analysis
(Nakamura et al., 2015).
ACCESSION NUMBERS
The RNA-seq data in this study were deposited in the NCBI database (GEO
accession number: GEO: GSE67259).), BTAG; BLIMP1+/ (middle), and BTAG; BLIMP1/ (bottom) hiPSCs through
regate induced from wild-type (wt: circle), BTAG; BLIMP1+/ (het: triangle), or
(wt) and BTAG; BLIMP1/ (ko) hiPSCs, as measured by qPCR. The quanti-
ibed in Figure 1F.
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